+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768290
  • Report
  • April 2019
  • Region: Global
  • 131 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • BridgeBio Pharma LLC
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • LEO Foundation
  • Mayne Pharma Group Ltd
  • MORE
The global clinical trial report- “2019 Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Basal Cell Carcinoma (Basal Cell Epithelioma). It presents in-depth analysis of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Basal Cell Carcinoma (Basal Cell Epithelioma).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Basal Cell Carcinoma (Basal Cell Epithelioma)

The research work is prepared through extensive and continuous research on Basal Cell Carcinoma (Basal Cell Epithelioma) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Basal Cell Carcinoma (Basal Cell Epithelioma) patients are identified
  • The report includes panorama of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BridgeBio Pharma LLC
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • LEO Foundation
  • Mayne Pharma Group Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Region
2.2.2 Average Enrollment of Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Basal Cell Carcinoma (Basal Cell Epithelioma) Treatment, 2019

3. Region wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
3.1 Asia Pacific Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Country
3.2 Europe Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Country
3.3 North America Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Country
3.4 Middle East and Africa Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Country
3.5 South and Central America Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Country

4. Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trial Trends
4.1 Start Year wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
4.2 Phase wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
4.3 Trial Status wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
4.4 Trial Type wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials

5. Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment Trends
5.1 Average Enrollment in Basal Cell Carcinoma (Basal Cell Epithelioma) Trials by Year
5.2 Average Enrollment in Basal Cell Carcinoma (Basal Cell Epithelioma) Trials by Phase
5.3 Average Enrollment in Basal Cell Carcinoma (Basal Cell Epithelioma) Trials by Status
5.4 Average Enrollment in Basal Cell Carcinoma (Basal Cell Epithelioma) Trials by Type of Trial

6. Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials
6.1 Basal Cell Carcinoma (Basal Cell Epithelioma) Trials by Sponsor Type
6.2 Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Basal Cell Carcinoma (Basal Cell Epithelioma) Trials- Phase 1
7.2 Basal Cell Carcinoma (Basal Cell Epithelioma) Trials- Phase 2
7.3 Basal Cell Carcinoma (Basal Cell Epithelioma) Trials- Phase 3
7.4 Basal Cell Carcinoma (Basal Cell Epithelioma) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Figure 7: North America - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Figure 9: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Phase
Figure 10: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Trial Status
Figure 11: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Type
Figure 12: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Sponsor Type
Figure 13: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials by Leading Sponsors
Figure 14: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Phase
Figure 15: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Trial Status
Figure 16: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Type
Figure 17: Basal Cell Carcinoma (Basal Cell Epithelioma)- Average Enrolment by Type of Sponsors
Figure 18: Basal Cell Carcinoma (Basal Cell Epithelioma)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Table 5: Europe - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Table 7: North America - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Basal Cell Carcinoma (Basal Cell Epithelioma) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Phase
Table 15: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Trial Status
Table 16: Basal Cell Carcinoma (Basal Cell Epithelioma) Average Enrollment by Type
Table 17: Basal Cell Carcinoma (Basal Cell Epithelioma)- Average Enrolment by Type of Sponsors
Table 18: Basal Cell Carcinoma (Basal Cell Epithelioma)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BridgeBio Pharma LLC
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Graceway Pharmaceuticals LLC
  • LEO Foundation
  • Mayne Pharma Group Ltd
  • Mylan NV
  • Nestle SA
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll